IGM Biosciences to Announce Fourth Quarter and Year-end 2019 Financial Results and Host Conference Call and Webcast on March ...
March 19 2020 - 7:00AM
IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage
biotechnology company focused on creating and developing engineered
IgM antibodies, today announced that it will report its fourth
quarter and year-end 2019 financial results on Thursday, March 26,
2020.
In connection with the earnings release, IGM’s management team
will host a live conference call and webcast at 4:30 p.m. ET on
Thursday, March 26, 2020, to discuss the Company’s financial
results and provide a corporate update.
Conference ID: 2991398Domestic Dial-in Number: (866)
649-1996International Dial-in Number: (409) 217-8769Live Webcast:
https://edge.media-server.com/mmc/p/vw87ve5n
A replay of the audio webcast will be available for 30 days on
the Investors section of the Company's website, www.igmbio.com.
About IGM Biosciences, Inc. Headquartered in
Mountain View, California, IGM Biosciences is a clinical-stage
biotechnology company focused on creating and developing engineered
IgM antibodies. Since 2010, IGM Biosciences has worked to overcome
the manufacturing and protein engineering hurdles that have limited
the therapeutic use of IgM antibodies. Through its efforts, IGM
Biosciences has created a proprietary IgM technology platform for
the development of IgM antibodies for those clinical indications
where their inherent properties may provide advantages as compared
to IgG antibodies.
Contact:
Argot Partners David Pitts212-600-1902
igmbio@argotpartners.com
IGM Biosciences (NASDAQ:IGMS)
Historical Stock Chart
From Jun 2024 to Jul 2024
IGM Biosciences (NASDAQ:IGMS)
Historical Stock Chart
From Jul 2023 to Jul 2024